View which stocks are hot on social media with MarketBeat's trending stocks report. Earnings for GlaxoSmithKline are expected to grow by 0.33% in the coming year, from $3.07 to $3.08 per share. See what's happening in the market right now with MarketBeat's real-time news feed. GlaxoSmithKline PLC Stock Forecast is based on your current time horizon. Dip below 35.99 ~ 35.70 range Twice , back up to 36.30 <---- 50+ cent gap ups. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. GSK updated stock price target summary. GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Sign-up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter. During the day the stock fluctuated 0.76% from a day low at $37.56 to a day high of $37.84. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GSK, but not buy additional shares or sell existing shares. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Glaxosmithkline's earnings in 2019 is $6,111,842,105.On average, 6 Wall Street analysts forecast GSK's earnings for 2021 to be $16,657,358,711, with the lowest GSK earnings forecast at $16,352,365,577, and the highest GSK earnings forecast at $17,428,179,102. With a 5-year investment, the revenue is expected to be around +8.55%. Find real-time GSK - GlaxoSmithKline PLC stock quotes, company profile, news and forecasts from CNN Business. View which stocks have been most impacted by COVID-19. Investors of record on Friday, November 13th will be paid a dividend of $0.4959 per share on Thursday, January 14th. Their forecasts range from GBX 1,300 to GBX 2,240. 19 brokers have issued 1 year price objectives for GlaxoSmithKline plc (GSK.L)'s shares. Fortunes will be made and lost in 2021 – and you likely have just weeks to decide which side you’ll be on. The Company makes a range of prescription medicines and vaccines … Factset: FactSet Research Systems Inc.2019. Ralph Lauren (NYSE: RL) Has Room To Run Another 30%, 3 Grocery Store Stocks to Put in Your Cart, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, 7 Things You Need To Know About Cryptocurrency, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, Receive Analysts' Upgrades and Downgrades Daily. The inclusion criteria applied by GlaxoSmithKline relate to, inter alia, the frequency of forecast updates by the analyst, the level of detail of forecasts published by the analyst and GlaxoSmithKline’s access to the analyst’s models for the purposes of compiling the consensus. GlaxoSmithKline is a leading dividend payer. Learn everything you need to know about successful options trading with this three-part video course. This indicates that GlaxoSmithKline will be able to sustain or increase its dividend. Your current $100 investment may be up to $108.55 in 2026. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. GlaxoSmithKline has a market capitalization of $96.68 billion and generates $43.10 billion in revenue each year. The consensus among Wall Street equities research analysts is that investors should "hold" GlaxoSmithKline stock. GSK’s share price has fallen by nearly 25% so far this year. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. All times are ET. GlaxoSmithKline trades on the New York Stock Exchange (NYSE) under the ticker symbol "GSK.". Based on our forecasts, a long-term increase is expected, the "GSK" stock price prognosis for 2025-12-23 is 1802.630 GBX. View insider buying and selling activity for GlaxoSmithKline or view top insider-selling stocks. Get daily stock ideas top-performing Wall Street analysts. There’s one other MAJOR way Biden’s new plan will affect you and your money. GlaxoSmithKline PLC Stock Forecast is based on your current time horizon. Vote “Underperform” if you believe GSK will underperform the S&P 500 over the long term. On average, they expect GlaxoSmithKline plc (GSK.L)'s stock price to reach GBX 1,763 in the next twelve months. The Glaxosmithkline plc - ADR stock forecast is 70.847354 USD for 2022 January 16, Sunday; and 267.671 USD for 2026 January 16, Friday with technical analysis. According to 6 analysts, the average rating for GSK stock is "Buy." Morningstar: © 2019 Morningstar, Inc. All Rights Reserved. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. This suggests a possible upside of … What this means: InvestorsObserver gives Glaxosmithkline Plc (GSK) an overall rank of 34, which is below average. View our earnings forecast for GlaxoSmithKline. Is GlaxoSmithKline a buy right now? A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend … GlaxoSmithKline PLC Stock Forecast Over the next 52 weeks, GlaxoSmithKline PLC has on average historically risen by 15 % based on the past 44 years of stock performance. 150,004 shares of the stock were exchanged, compared to its average … © 2020 Cable News Network. PEG Ratios above 1 indicate that a company could be overvalued. The 12-month stock price forecast is 48.50, which is an increase of 26.07% from the latest price. Learn about financial terms, types of investments, trading strategies and more. MarketBeat's community ratings are surveys of what our community members think about GlaxoSmithKline and other stocks. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Glaxosmithkline stock was originally listed at a price of $47.88 in Dec 31, 1997. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. The pharmaceutical company earns $5.93 billion in net income (profit) each year or $3.17 on an earnings per share basis. Shares of GSK can be purchased through any online brokerage account. This represents a $1.98 dividend on an annualized basis and a yield of 5.15%. Chief Scientific Officer, Pres of R&D and Director, Sr. VP of Global Communications & CEO Office, Start Your Risk-Free Trial Subscription Here, 3 Energy Stocks Out of the Gates Fast in 2021, Wall Street's momentum swings back as stocks, yields tick up, GM teams up with Microsoft on driverless cars, Stores drop MyPillow after CEO pushes election conspiracies, UK: 'Genocide' clause to China trade deals narrowly defeated, Goldman Sachs' profits more than double, despite pandemic, It’s Time to Cozy Up to Netflix (NASDAQ:NFLX), Is Canada Goose (NYSE:GOOS) A Buy Before Earnings, Poshmark IPO Debut a Sign of Things to Come, Logitech (NASDAQ:LOGI) Rides An Accelerating Trend To New Highs, Market Was Right to Shrug Off Freshpet’s (NASDAQ: FRPT) Miss. Export data to Excel for your own analysis. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. With Covid vaccine News coming any day now - … However, solely looking at the historical price movement is usually misleading. Fundamental company data provided by Morningstar and Zacks Investment Research. It has collaboration agreements with 23andMe; Merck KGaA; Lyell Immunopharma; CEPI; Innovax and Xiamen University; VBI; Viome; Sanofi SA; CureVac; and research collaboration with Sengenics focusing on immunology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. GlaxoSmithKline has only been increasing its dividend for 1 years. Glaxosmithkline Plc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. Do Not Sell My Information. This payout ratio is at a healthy, sustainable level, below 75%. If you had invested in Glaxosmithkline stock at $47.88, your return over the last 23 years would have been -19.92%, for an annualized return of -0.96%. Next Steps Explore strong dividend paying … GSK stock was sold by a variety of institutional investors in the last quarter, including Chemung Canal Trust Co., Fulton Bank N.A., City Holding Co., Raymond James Trust N.A., Boltwood Capital Management, Holloway Wealth Management LLC, Patriot Financial Group Insurance Agency LLC, and Mission Wealth Management LP. Top institutional investors include Douglas Lane & Associates LLC (0.05%), Galibier Capital Management Ltd. (0.02%), Jacobs & Co. CA (0.01%), Holloway Wealth Management LLC (0.00%), Signature Wealth Management Group (0.00%) and Old Port Advisors (0.00%). The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. Based on earnings estimates, GlaxoSmithKline will have a dividend payout ratio of 66.23% next year. A rank of 34 means that 66% of stocks appear more favorable to our system. The dividend payout ratio of GlaxoSmithKline is 64.35%. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. That leaves the stock trading on just 12 times forecast earnings, with a dividend yield of 5.8%. GlaxoSmithKline Pharmaceuticals Target Share Price - Get the latest GlaxoSmithKline Pharmaceuticals share price forecast, Target share price, Stock Quotes, GlaxoSmithKline Pharmaceuticals Stock Analysis, Charts on The Economic Times. GlaxoSmithKline had a net margin of 18.50% and a return on equity of 29.60%. There is not enough analysis data for GlaxoSmithKline. (Add your “underperform” vote.). All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2019 and/or its affiliates. GlaxoSmithKline has received 764 “outperform” votes. Most stock quote data provided by BATS. Want to see which stocks are moving? I dont see much Downside as Compared to upside. Is the Beyond Meat (NASDAQ: BYND) Rally Sustainable? With a 5-year investment, the revenue is expected to be around +34.32%. GSK Stock Trend. GLAXOSMITHKLINE PLC : Forcasts, revenue, earnings, analysts expectations, ratios for GLAXOSMITHKLINE PLC Stock | GSK | GB0009252882 The Next Few Weeks Could Decide Your Wealth in ‘21. We don’t hear much about the patent cliff anymore, but it’s still a real … Find the latest dividend history for GlaxoSmithKline PLC Common Stock (GSK) at Nasdaq.com. You may vote once every thirty days. Vote “Outperform” if you believe GSK will outperform the S&P 500 over the long term. This payout ratio is at a healthy, sustainable level, below 75%. Glaxosmithkline Plc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. The GlaxoSmithKline PLC stock price gained 0.59% on the last trading day (Wednesday, 13th Jan 2021), rising from $37.46 to $37.68. The firm has a market capitalization of $96.65 billion, a price-to-earnings ratio of 11.82, a price-to-earnings-growth ratio of 2.93 and a beta of 0.67. GlaxoSmithKline's management team includes the following people: Biden’s New Plan – What No One is Telling You. View GlaxoSmithKline's earnings history. The average price target represents a -100.00% upside from the last price of $36.80. Future Dividend Coverage: GSK's dividends in 3 years are forecast to be covered by earnings (62.1% payout ratio). The stock is moving within a wide and horizontal trend and further movements within this trend can be expected. Disclaimer. A Warner Media Company. All rights reserved. gsk $38.47 $0.31 0.8% Price as of January 15, 2021, 9:00 p.m. EST View Interactive GSK Charts The price has been going up and down for this period, and there has been a 1.89% gain for the last 2 weeks. All rights reserved. GlaxoSmithKline employs 99,437 workers across the globe. This indicates that GlaxoSmithKline will be able to sustain or increase its dividend. Price Target (Add your “outperform” vote. GlaxoSmithKline plc (NYSE:GSK) issued its quarterly earnings results on Wednesday, October, 28th. Based on aggregate information from My MarketBeat watchlists, some companies that other GlaxoSmithKline investors own include AT&T (T), Pfizer (PFE), Johnson & Johnson (JNJ), Verizon Communications (VZ), Cisco Systems (CSCO), AbbVie (ABBV), Intel (INTC), Gilead Sciences (GILD), The Walt Disney (DIS) and NVIDIA (NVDA). Based on our forecasts, a long-term increase is expected, the "GSK" stock price prognosis for 2025-12-23 is 39.945 USD. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. CNN Sans™ & © 2016 Cable News Network. The dividend payout ratio of GlaxoSmithKline is 64.35%. The Company operates through two segments: Pharmaceuticals and Vaccines. This is a boost from GlaxoSmithKline's previous quarterly dividend of $0.49. The P/E ratio of GlaxoSmithKline is 11.86, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 23.54. All Rights Reserved. GlaxoSmithKline pays an annual dividend of $2.04 per share and currently has a dividend yield of 5.30%. The P/E ratio of GlaxoSmithKline is 11.86, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 35.43. View which stocks have been most impacted by COVID-19. Jan 15 / Zacks.com - Paid Partner Content, Jan 12 / MotleyFool.com - Paid Partner Content, Jan 14 / MotleyFool.com - Paid Partner Content, Jan 12 / Zacks.com - Paid Partner Content, Jan 13 / Zacks.com - Paid Partner Content, Jan 08 / Zacks.com - Paid Partner Content, Jan 07 / Zacks.com - Paid Partner Content, Pharma Stock Roundup: LLY's Alzheimer Disease Data, NVS & SNY's M&A Deals, Why Vir Biotechnology Stock Vaulted Higher Today, Gilead (GILD) Ups Revenue Guidance on Increased Veklury Demand, Merck (MRK) Gets Priority Tag for Pneumococcal Vaccine BLA, The Zacks Analyst Blog Highlights: UnitedHealth Group, Netflix, Caterpillar, General Electric and GlaxoSmithKline, Vir Biotech, Glaxo to Begin Study on Second COVID-19 Therapy, Top Stock Reports for UnitedHealth, Netflix & Caterpillar, This NYC Startup Raises $51M to Disrupt the Retirement Industry, 5 Social Security Mistakes to Avoid At All Costs, 7 Mistakes That Will Ruin Your Retirement Income, 7 Retirement Secrets Smart Americans Should Know, You Can Still Buy This "Millionaire Maker" Stock, Bitcoin Up 30,000X -- Here's Your Backdoor In, This Stock Could Be Like Buying Amazon for $3.19. © American Consumer News, LLC dba MarketBeat® 2010-2021. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. View analyst ratings for GlaxoSmithKline or view MarketBeat's top 5 stock picks. GlaxoSmithKline is scheduled to release its next quarterly earnings announcement on Wednesday, February 3rd 2021. GSK Stock is A bit Undervalued RIght now.. Institutions have price targets of 42~-48 back on the Covid-low-trendline .. GlaxoSmithKline PLC has risen higher in 26 of those 44 years over the subsequent 52 week period, corresponding to a historical probability of 59 % The ex-dividend date of this dividend is Thursday, November 12th. The pharmaceutical company earned $11.17 billion during the quarter, compared to analyst estimates of $11.27 billion. Glaxosmithkline plc - ADR (GSK) stock price prediction is 70.847354 USD. There are currently 2 sell ratings, 5 hold ratings and 6 buy ratings for the stock. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. One share of GSK stock can currently be purchased for approximately $38.54. View GlaxoSmithKline's dividend history. GSK Stock Summary. Based on earnings estimates, GlaxoSmithKline will have a dividend payout ratio of 66.23% next year. GSK stock traded up $0.12 during mid-day trading on Tuesday, hitting $38.59. GLAXOSMITHKLINE PLC earnings per share revisions and analysts forecast | London Stock Exchange: GSK | London Stock Exchange GlaxoSmithKline PLC is a global healthcare company. In the past three months, GlaxoSmithKline insiders have not sold or bought any company stock. 323,181 shares of the stock traded hands, compared to its average volume of 4,043,910. However, solely looking at the historical price movement is usually misleading. ), GlaxoSmithKline has received 1,115 “underperform” votes. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. GlaxoSmithKline's stock is owned by many different institutional and retail investors. GSK Stock Analysis Overview . Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Get Our PREMIUM Forecast Now, from ONLY $6.69! GSK stock was acquired by a variety of institutional investors in the last quarter, including Galibier Capital Management Ltd., Douglas Lane & Associates LLC, Gilman Hill Asset Management LLC, Jacobs & Co. CA, SevenBridge Financial Group LLC, Bonness Enterprises Inc., Signature Wealth Management Group, and Crescent Capital Consulting LLC. Receive a free world-class investing education from MarketBeat. This price target is based on 12 analysts offering 12 month price targets for GlaxoSmithKline in the last 3 months. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. What this means: InvestorsObserver gives Glaxosmithkline Plc (GSK) an overall rank of 33, which is below average. GlaxoSmithKline does not yet have a strock track record of dividend growth. GlaxoSmithKline's stock was trading at $39.87 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Identify stocks that meet your criteria using seven unique stock screeners. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 The pharmaceutical company reported $0.92 EPS for the quarter, topping the Zacks' consensus estimate of $0.78 by $0.14. Learn more. Learn more. Your current $100 investment may be up to $134.32 in 2026. Only 11.83% of the stock of GlaxoSmithKline is held by institutions. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency v irus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases. View all of GSK's competitors. Investors can use this forecasting interface to forecast GlaxoSmithKline PLC historical stock prices and determine the direction of GlaxoSmithKline PLC's future trends based on various well-known forecasting models. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. GlaxoSmithKline PLC (GSK:LSE) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. The pharmaceutical company can be reached via phone at 44-20-8047-5000 or via email at [email protected]. The official website for GlaxoSmithKline is www.gsk.com. Some companies that are related to GlaxoSmithKline include Roche (RHHBY), Novartis (NVS), Merck & Co., Inc. (MRK), Pfizer (PFE), Abbott Laboratories (ABT), AbbVie (ABBV), Eli Lilly and (LLY), Novo Nordisk A/S (NVO), Bristol-Myers Squibb (BMY), AstraZeneca (AZN), Sanofi (SNY), CSL (CSLLY), Zoetis (ZTS), Vertex Pharmaceuticals (VRTX) and Bayer Aktiengesellschaft (BAYRY). Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Glaxosmithkline Plc's stock had its IPO on July 9, 1986, making it an older stock than 92.32% of US equities in our set. View insider buying and selling activity for GlaxoSmithKline or or view top insider-buying stocks. See GlaxoSmithKline PLC (GSK) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. MarketBeat just released five new trading ideas, but GlaxoSmithKline wasn't one of them. Looking for new stock ideas? Given the current horizontal trend, you can expect GlaxoSmithKline PLC stock with a 90% probability to be traded between $33.98 and $39.74 at the end of this 3-month period. Since then, GSK stock has decreased by 3.3% and is now trading at $38.54. You can opt out at any time. GlaxoSmithKline has a P/B Ratio of 4.10. GlaxoSmithKline has a PEG Ratio of 2.93. GSK has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Wall Street analysts have given GlaxoSmithKline a "Hold" rating, but there may be better short-term opportunities in the market. To see all exchange delays and terms of use please see disclaimer. Only 10.00% of the stock of GlaxoSmithKline is held by insiders. View our full suite of financial calendars and market data tables, all for free. Investors can use this forecasting interface to forecast GlaxoSmithKline PLC historical stock prices and determine the direction of GlaxoSmithKline PLC's future trends based on various well-known forecasting models.

Ultima 2 Perfume, Hideaway Royalton Cancun, Fatal Car Accident Nashville, Tn Today, Tackle Industries Super D, Where To Buy Dogs In Virginia, Elenker Knee Walker Hfk-9225, Delectables Squeeze Up Discontinued, Words To Live By Also A Popular Men's Magazine, Lego Minifigure Display Frame,


Avatar